Pseudophakia and Lens Opacities in 70-Year-Olds in Gothenburg, Sweden;
Identifying correlations between lens opacities, visual acuity and subjective visual function, and to validate self-reported cataract and cataract surgery
Source: dovepress.com
Page 2 - Corrected Visual Acuity News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Corrected Visual Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Corrected Visual Acuity Today - Breaking & Trending Today
GenSight Biologics Confirms Sustained Efficacy and Safety of Bilateral LUMEVOQ® Injections at 2-Year Follow-Up of REFLECT Phase III Trial
PARIS--(BUSINESS WIRE)--Dec 14, 2021--
Source: nwitimes.com
GenSight Biologics Announces Publication of Indirect Comparison Showing Treatment Effect of LUMEVOQ® versus Natural History in Frontiers in Neurology
Clinically meaningful difference between visual outcomes of LUMEVOQ®-treated patients and untreated patients Regulatory News: GenSight Biologics ...
Source: benzinga.com
GenSight Biologics Announces Publication of Results from LUMEVOQ RESCUE Pivotal Phase III Trial in AAO journal Ophthalmology
Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that the journal of the American Academy of Ophthalmology, Ophthalmology ® gene therapy in ND4 Leber Hereditary Optic Neuropathy (LHON) subjects. The paper*, published in the January issue under the title, “Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated with...
Source: financialbuzz.com